Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
Nat Commun. 2022 Mar 9;13(1):1220. doi: 10.1038/s41467-022-28905-5.
Nat Commun. 2022.
PMID: 35264564
Free PMC article.